Month: January 2025

Municipality Finance issues a NOK 1 billion tap under its MTN programme

Written by Customer Service on January 29, 2025. Posted in Public Companies.

Municipality Finance PlcStock exchange release 29 January 2025 at 10:00 am (EET) Municipality Finance issues a NOK 1 billion tap under its MTN programme On 30 January 2025 Municipality Finance Plc issues a new tranche in an amount of NOK 1 billion to an existing series of notes issued on 15 January 2025. With the new tranche, the aggregate nominal amount of the notes is NOK 4 billion. The maturity date of the notes is 15 January 2030. The notes bear interest at a floating rate equal to 3-month Nibor plus 25 bps per annum. The new tranche is issued under MuniFin’s EUR 50 billion programme for the issuance of debt instruments. The offering circular, the supplemental offering circular and final terms of the notes are available in English on the company’s website at https://www.kuntarahoitus.fi/en/for-investors. MuniFin has applied...

Offentliggørelse af prospekt samt formue og investorer for afdelingen I&T Obligationer KL i Investeringsforeningen Wealth Invest

Written by Customer Service on January 29, 2025. Posted in Public Companies.

Hermed offentliggøres prospekt samt formue og antal investorer for afdelingen I&T Obligationer KL, som optages til handel på Nasdaq Copenhagen A/S med første handelsdag 31. januar 2025.Afdeling Formue DKK Antal navnenoterede investorerI&T Obligationer 17.765.000 169Hvis der måtte være spørgsmål i relation til ovenstående, kan der rettes henvendelse til direktør i Wealth Fund Partners A/S, Lise Bøgelund Jensen på telefon 3328 2828. Med venlig hilsen Investeringsforeningen Wealth InvestAttachment2025 01 31 WI I&T_børsprospekt_final

Borregaard ASA: EBITDA1 of NOK 398 million in the 4th quarter

Written by Customer Service on January 29, 2025. Posted in Earnings Releases And Operating Results.

Borregaard’s operating revenues were NOK 1,744 million (NOK 1,605 million)2 in the 4th quarter of 2024. EBITDA1 reached NOK 398 million (NOK 327 million). The result in BioSolutions increased compared with the 4th quarter of 2023. BioMaterials remained at the same level, while there was a decrease in Fine Chemicals. Increased sales were the main reason for the strong result in BioSolutions. For BioMaterials, higher sales volume and an improved product mix of speciality cellulose were offset by increased wood costs. Lower deliveries were the main reason for the weaker result in Fine Chemicals. The net currency effects were positive. Other income and expenses1 were NOK -30 million in the 4th quarter of 2024. This accrual was for remediation of contaminated soil at the Sarpsborg site. Profit before tax was NOK 170 million (NOK 135 million)....

ASML reports €28.3 billion total net sales and €7.6 billion net income in 2024

Written by Customer Service on January 29, 2025. Posted in Earnings Releases And Operating Results.

ASML reports €28.3 billion total net sales and €7.6 billion net income in 2024 2025 total net sales expected to be between €30 billion and €35 billion VELDHOVEN, the Netherlands, January 29, 2025 – Today, ASML Holding NV (ASML) has published its 2024 fourth-quarter and full-year results. Q4 total net sales of €9.3 billion, gross margin of 51.7%, net income of €2.7 billion Quarterly net bookings in Q4 of €7.1 billion2 of which €3.0 billion is EUV 2024 total net sales of €28.3 billion, gross margin of 51.3%, net income of €7.6 billion ASML expects Q1 2025 total net sales between €7.5 billion and €8.0 billion, and a gross margin between 52% and 53% ASML expects 2025 total net sales to be between €30 billion and €35 billion, with a gross margin between 51% and 53%(Figures in millions of euros unless otherwise indicated) Q3 2024...

ONWARD Medical’s ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms

Written by Customer Service on January 29, 2025. Posted in Public Companies.

ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms Partnership with Lovell Government Services is providing commercial benefit, facilitating purchase through validated US government online purchasing platforms EINDHOVEN, the Netherlands, Jan. 29, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities today announces it has secured the required approvals to enable Veterans Affairs (VA) and other government agencies to immediately purchase the ARC-EX System through federal procurement systems. This milestone is the first major benefit resulting...

Webuy Global Ltd. Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Rule

Written by Customer Service on January 29, 2025. Posted in Public Companies.

Singapore, Jan. 28, 2025 (GLOBE NEWSWIRE) — Webuy Global Ltd. (Nasdaq: WBUY) (the “Company”), today announced that it received a letter on January 22, 2025, from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. As a result, the Nasdaq staff has issued a Staff Delisting Determination, and the trading of the Company’s Class A ordinary shares will be suspended at the opening of business on January 29, 2025. The Minimum Bid Price Rule requires listed securities to achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the compliance period. Despite...

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Written by Customer Service on January 29, 2025. Posted in Public Companies.

SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the pricing of its previously announced upsized underwritten public offering of 21,671,428 shares of its common stock at a public offering price per share of $8.75 and, in lieu of common stock to a certain investor, pre-funded warrants to purchase up to 6,900,000 shares of its common stock at a public offering price of $8.749. The pre-funded warrants have an exercise price of $0.001 per share and are exercisable immediately. In addition, 89bio has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 4,285,714...

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Written by Customer Service on January 29, 2025. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today the pricing of an upsized underwritten public offering of 5,333,420 shares of its common stock at a public offering price of $48.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 1,958,247 shares of common stock at a public offering price of $47.9999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants in the offering are being offered by Akero. In addition,...

First Savings Financial Group, Inc. Reports Financial Results for the First Fiscal Quarter Ended December 31, 2024

Written by Customer Service on January 29, 2025. Posted in Earnings Releases And Operating Results.

JEFFERSONVILLE, Ind., Jan. 28, 2025 (GLOBE NEWSWIRE) — First Savings Financial Group, Inc. (NASDAQ: FSFG – news) (the “Company”), the holding company for First Savings Bank (the “Bank”), today reported net income of $6.2 million, or $0.89 per diluted share, for the quarter ended December 31, 2024, compared to net income of $920,000, or $0.13 per diluted share, for the quarter ended December 31, 2023. Excluding nonrecurring items, the Company reported net income of $4.3 million (non-GAAP measure)(1) and net income per diluted share of $0.62 (non-GAAP measure)(1) for the quarter ended December 31, 2024 compared to $920,000, or $0.13 per diluted share for the quarter ended December 31, 2023. The core banking segment reported net income of $6.4 million, or $0.91 per diluted share, for the quarter ended...

Wearable Devices Ltd. Announces Pricing of $2.5 Million Public Offering

Written by Customer Service on January 29, 2025. Posted in Public Companies.

Yokneam Illit, Israel, Jan. 28, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, today announced the pricing of its “reasonable best efforts” public offering with a single institutional investor for the purchase and sale of up 2,500,000 ordinary shares (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,500,000 ordinary shares, at a combined offering price of $1.00 per share and accompanying warrant (the “Offering”). The Company expects to receive aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees and other offering expenses and assuming no exercise of the warrants. The warrants will have an exercise...

Month: January 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals